RECOMMENDATIONS OF THE EXPERT PANEL ON ETHICAL ISSUES IN CLINICAL TRIALS OF TRANSPLANT TOLERANCE
REGULATED AND ENDOTHELIAL CELL-SPECIFIC EXPRESSION OF FAS LIGAND
A STABLE PROSTACYCLIN ANALOG, BERAPROST SODIUM, ATTENUATES PLATELET ACCUMULATION AND PRESERVATION-REPERFUSION INJURY OF ISOGRAFTS IN A RAT MODEL OF LUNG TRANSPLANTATION1
COLD PRESERVATION OF THE PORCINE PANCREAS WITH HISTIDINE-TRYPTOPHAN-KETOGLUTARATE SOLUTION
QUALITY OF LIFE OF PATIENTS AFTER INTESTINAL TRANSPLANTATION
ANALYSIS OF THE RENAL TRANSPLANT WAITING LIST
THE NEW EUROTRANSPLANT KIDNEY ALLOCATION SYSTEM1
RENAL TRANSPLANTATION WITH LIMIT DONORS
HEMODYNAMIC FOLLOW-UP OF CARDIAC ALLOGRAFTS FROM POISONED DONORS
STABLE LUNG ALLOGRAFT OUTCOME CORRELATES WITH THE PRESENCE OF INTRAGRAFT DONOR-DERIVED LEUKOCYTES1
EFFICACY AND MUSCLE SAFETY OF FLUVASTATIN IN CYCLOSPORINE-TREATED CARDIAC AND RENAL TRANSPLANT RECIPIENTS
REVERSAL OF EARLY ACUTE REJECTION WITH INCREASED DOSES OF TACROLIMUS IN LIVER TRANSPLANTATION
LONG-TERM OUTCOME OF A PROSPECTIVE RANDOMIZED TRIAL OF CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE TREATMENT ONE YEAR AFTER RENAL TRANSPLANTATION1
COMPARATIVE INCIDENCE OF DE NOVO NONLYMPHOID MALIGNANCIES AFTER LIVER TRANSPLANTATION UNDER TACROLIMUS USING SURVEILLANCE EPIDEMIOLOGIC END RESULT DATA1
INCIDENCE AND MANAGEMENT OF BILIARY COMPLICATIONS AFTER 291 LIVER TRANSPLANTS FOLLOWING THE INTRODUCTION OF TRANSCYSTIC STENTING
STEROID-FREE IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION WITH ANTITHYMOCYTE GLOBULIN INDUCTION AND CYCLOSPORINE AND MYCOPHENOLATE MOFETIL MAINTENANCE THERAPY
MEMBRANE-ASSOCIATED LYMPHOTOXIN ON NATURAL KILLER CELLS ACTIVATES ENDOTHELIAL CELLS VIA AN NF-κB-DEPENDENT PATHWAY1
INTERLEUKIN-10 DOSE-DEPENDENT REGULATION OF CD4+ AND CD8+ T CELL-MEDIATED GRAFT-VERSUS-HOST DISEASE1
ENDOTHELIAL CELL ACTIVATION BY SERA CONTAINING HLA ANTIBODIES IS MEDIATED BY INTERLEUKIN-1
ROLE OF DONOR AND RECIPIENT ANTIGEN-PRESENTING CELLS IN PRIMING AND MAINTAINING T CELLS WITH INDIRECT ALLOSPECIFICITY1
SULFATION-DEPENDENT DOWN-REGULATION OF INTERFERON-γ-INDUCED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I AND II AND INTERCELLULAR ADHESION MOLECULE-1 EXPRESSION ON TUBULAR AND ENDOTHELIAL CELLS BY GLYCOSAMINOGLYCANS1
ACUTE INTESTINAL GRAFT-VERSUS-HOST DISEASE IN A SYNGENEIC BONE MARROW TRANSPLANT RECIPIENT
HEPATITIS C VIRUS-ASSOCIATED FIBROSING CHOLESTATIC HEPATITIS AFTER RENAL TRANSPLANTATION
POSTTRANSPLANT HEMOLYTIC UREMIC SYNDROME IN ADULT RETRANSPLANTED KIDNEY GRAFT RECIPIENTS: ADVANTAGE OF FK506 THERAPY?
Announcements
ERRATUM